Tag - medicine

 
 

MEDICINE

Japan Times
WORLD / Science & Health / FOCUS
Nov 24, 2020
Decades of work, and half a dose of fortune, drove Oxford vaccine success
The Oxford vaccinologists were exhilarated on Monday when drugmaker AstraZeneca, with whom they developed the shot, announced that it could be around 90% effective.
Japan Times
WORLD
Nov 23, 2020
U.S. plans first vaccinations in weeks, Operation Warp Speed chief says
Vaccinations against COVID-19 in the U.S. will "hopefully” start in less than three weeks, according to the head of the federal government’s program to accelerate a vaccine.
Japan Times
COMMENTARY / Japan
Nov 22, 2020
The new normal that will arise after COVID-19
In the post-COVID-19 world, the coronavirus should prove far less dangerous, eventually becoming as common as the flu. But that doesn't mean life will completely revert to the way it was.
Japan Times
COMMENTARY
Nov 22, 2020
Pfizer vaccine's safety milestone is just the beginning
As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.
Japan Times
JAPAN / Media / MEDIA MIX
Nov 21, 2020
A frank conversation is needed on euthanasia
In October, New Zealand voters approved a referendum proposal to legalize medically assisted suicide, thus joining a small group of countries and territories that allow euthanasia under specific circumstances. The proposal sprang from a lawsuit brought by a lawyer dying from a brain tumor, and while...
Japan Times
WORLD / Science & Health
Nov 21, 2020
Two companies say their vaccines are 95% effective. What does that mean?
You might assume that 95 out of every 100 people vaccinated will be protected from COVID-19. But that's not how the math works.
Japan Times
JAPAN
Nov 20, 2020
Hospitals in Japan's hard-hit areas stretched amid COVID-19 surge
There is concern that a rising trend in the number of severely ill patients could overwhelm hospitals, health care facilities and intensive care units, delaying critical care.
Japan Times
COMMENTARY / World
Nov 20, 2020
What COVID-19 is costing women?
The pandemic has compounded a longstanding problem for women around the world: large and persistent barriers to participating in the economy and public life on an equal basis with men.
Japan Times
WORLD / Science & Health
Nov 20, 2020
WHO advises doctors not to use Gilead’s remdesivir for COVID-19
The recommendation is a blow to Gilead's drug, which was one of the first thought to offer a meaningful benefit in treatment of coronavirus patients.
Japan Times
COMMENTARY / World
Nov 19, 2020
COVID-19 mutated. Can vaccines keep up?
So far, scientists have found only one mutation that improves the survival ability of the virus. The more transmissible strain is referred to as G614.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Can first vaccines bring herd immunity? Experts have doubts.
Figuring out what's needed to achieve herd immunity with COVID-19 vaccines involves a range of factors, several of which are unknown.
Japan Times
WORLD / Science & Health
Nov 19, 2020
Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'
Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.
Japan Times
COMMENTARY / Japan
Nov 18, 2020
Can Japan bridge the vaccine divide?
Japan too has been developing its own drug, Avigan, against COVID-19. Yet the drug being developed by Fujifilm is not a vaccine but rather a treatment for coronavirus symptoms.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
China takes risk in rushing to use unproven coronavirus vaccines
China has made its unproven candidates widely available to demonstrate their safety and effectiveness to a country that has long been skeptical of vaccines.
Japan Times
ASIA PACIFIC / Science & Health
Nov 18, 2020
Sinovac's COVID-19 vaccine induces quick immune response, study finds
Sinovac Biotech's experimental COVID-19 vaccine CoronaVac triggered a quick immune response but the level of antibodies produced was lower than in people who had recovered from the disease, preliminary trial results showed on Wednesday.
Japan Times
WORLD / Science & Health
Nov 18, 2020
Pfizer reaches safety milestone for COVID-19 vaccine, CEO says
Pfizer Inc. Chief Executive Officer Albert Bourla said that a key safety milestone had been reached in the study of its COVID-19 vaccine, and the drugmaker is now preparing to seek an emergency-use authorization from U.S. regulators.
Japan Times
WORLD / Science & Health / FOCUS
Nov 18, 2020
How Pfizer and BioNTech sprinted ahead in extraordinary race for a COVID-19 vaccine
Researchers were asked to tackle something that had never been done before: design a vaccine to stop a pandemic in its tracks in less than a year.

Longform

Totopa in Tokyo’s Shinjuku Ward was picked by consultants TTNE as the best sauna of the year.
Japan’s sauna movement: Relax, refresh, repeat